Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

KYMR holding history

Kymera Therapeutics, Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KYMR overviewAll 13F holders of KYMRFull Q2 2026 holdings

Shares (Q2 2026)
97,189
Value
$11.1M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of KYMR by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202697,189$11.1M<0.1%+84,350+657.0%AddedHolders
Q1 202612,839$1.07M<0.1%−146,587−91.9%ReducedHolders
Q4 2025159,426$12.4M<0.1%−191,820−54.6%ReducedHolders
Q3 2025351,246$19.9M<0.1%+317,922+954.0%AddedHolders
Q2 202533,324$1.45M<0.1%−15,865−32.3%ReducedHolders
Q1 202549,189$1.35M<0.1%+815+1.7%AddedHolders
Q4 202448,374$1.95M<0.1%−25,151−34.2%ReducedHolders
Q3 202473,525$3.48M<0.1%−35,038−32.3%ReducedHolders
Q2 2024108,563$3.24M<0.1%+23,312+27.3%AddedHolders
Q1 202485,251$3.43M<0.1%+57,053+202.3%AddedHolders
Q4 202328,198$717.9K<0.1%−2,190−7.2%ReducedHolders
Q3 202330,388$422.4K<0.1%+30,388NewHolders
Q1 20230$00.0%−21,878−100.0%Sold outHolders
Q4 202221,878$546.1K<0.1%−97,003−81.6%ReducedHolders
Q3 2022118,881$2.59M<0.1%+39,553+49.9%AddedHolders
Q2 202279,328$1.56M<0.1%+79,328NewHolders
Q4 20210$00.0%−14,499−100.0%Sold outHolders
Q3 202114,499$852.0K<0.1%−34,316−70.3%ReducedHolders
Q2 202148,815$2.37M<0.1%+34,404+238.7%AddedHolders
Q1 202114,411$560.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.